Power based association analysis (PBAT) of serotonergic and noradrenergic polymorphisms in bipolar patients with suicidal behaviour.
OBJECTIVE
Suicidality is a major health concern worldwide particularly in affective disorder patients. Attempted suicide is familial. There is strong neurobiological evidence showing that serotonergic and noradrenergic dysfunction is implicated in suicidal behaviours. We will apply now a new family based association strategy aimed to explain the genetic influence in suicidal behaviour by power based association test statistics (PBAT) in 336 bipolar patients assessed for suicidality within nuclear families.


METHODS
By use of conditional power calculations, the approach screens all possible null hypotheses without biasing the nominal significance level, and it identifies the subset of phenotypes that has optimal power when tested for association by either univariate or multivariate family based association test (FBAT). Using this statistical approach (PBAT) we investigated polymorphisms in serotonergic and noradrenergic genes, considering suicidal behaviour severity instead of the dichotomous phenotype (presence of suicide attempt).


RESULTS
COMT Val/Met polymorphism was not associated with suicide with high confidence (power=91%). On the other hand, the analysis of the other 12 markers in the adrenergic and serotonergic genes revealed that the TH allele tended towards association with higher severity of suicidal behaviour (p=0.060) but the power obtained was very low.


CONCLUSIONS
The marginal finding of association between TH and severe suicidal behaviour are convergent with previous reports. On the other hand, our sample has enough power to exclude the other polymorphisms investigated as major candidate for suicidality in bipolar disorder.
De Luca
Vincenzo
V
Centre for Addiction and Mental Health, Department of Psychiatry, University of Toronto, ON, Canada. Vincenzo_Deluca@camh.net
Strauss
John
J
Kennedy
James L
JL
D000293:Adolescent; D000328:Adult; D000368:Aged; D000483:Alleles; D001714:Bipolar Disorder / Q000235:genetics* / Q000523:psychology*; D002394:Catechol O-Methyltransferase / Q000235:genetics; D005260:Female; D005787:Gene Frequency; D006801:Humans; D008297:Male; D008715:Methionine / Q000235:genetics; D008875:Middle Aged; D009638:Norepinephrine / Q000235:genetics*; D011110:Polymorphism, Genetic; D012701:Serotonin / Q000235:genetics*; D013057:Spectrum Analysis / Q000379:methods; D013405:Suicide; D014446:Tyrosine 3-Monooxygenase; D014633:Valine / Q000235:genetics
D012701:Serotonin; D008715:Methionine; D014446:Tyrosine 3-Monooxygenase; D002394:Catechol O-Methyltransferase; D014633:Valine; D009638:Norepinephrine